| Stage | UFPI | % of rev | HLNE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.9B | 100.00% | $275M | 100.00% | UFPI ×6.84 |
| Gross profit | $290M | 15.41% | $168M | 60.90% | HLNE +45.5pp |
| Operating income | $103M | 5.49% | $126M | 45.93% | HLNE +40.4pp |
| Pre-tax income | $113M | 5.99% | $150M | 54.47% | HLNE +48.5pp |
| Net income | $83M | 4.42% | $125M | 45.36% | HLNE +40.9pp |
| Stage | UFPI | HLNE | Gap · A − B |
|---|---|---|---|
| Revenue | $1.9B100.00% | $275M100.00% | UFPI ×6.84 |
| Gross profit | 15.41%$290M | 60.90%$168M | HLNE +45.5pp |
| Operating income | 5.49%$103M | 45.93%$126M | HLNE +40.4pp |
| Pre-tax income | 5.99%$113M | 54.47%$150M | HLNE +48.5pp |
| Net income |
| 4.42%$83M |
| 45.36%$125M |
| HLNE +40.9pp |
No shared counterparties.